Payment overview · 2025
General Payments
$128.59
8 reported records · 5 companies
Healthcare provider profile · identity verified
Ross B Vaughn, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · TUSCALOOSA, AL · NPI 1184715021
Verified facts
What the public records show
CMS Open Payments records show Ross B Vaughn, M.D. received $128.59 in general payments during 2025 across 8 reported records.
Abbott Laboratories accounted for 27.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Eliquis, Mounjaro.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 161 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 148 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 103 claims for Ozempic by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 691 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 37 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $35.11 | 27.3% | 2 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $31.77 | 24.7% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $31.65 | 24.6% | 2 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $15.54 | 12.1% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $14.52 | 11.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $128.59 | 8 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $35.11 | 2 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $31.65 | 2 | 2025 |
Source payment records
|
|||||
| ELIQUIS Normalized: eliquis |
Drug | PFIZER INC. | $16.18 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $15.59 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $15.59 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $15.54 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $14.52 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ELIQUIS eliquis |
2025 | Eliquis | 2024 | 691 | exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 148 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
161 | 36 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
148 | 23 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
25 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
103 | 15 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
691 | 107 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
37 | 37 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1618 | 348 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1418 | 348 |
| Amlodipine Besylate | Amlodipine Besylate | 987 | 240 |
| Pantoprazole Sodium | Pantoprazole Sodium | 908 | 201 |
| Eliquis | Apixaban | 691 | 107 |
| Losartan Potassium | Losartan Potassium | 654 | 161 |
| Potassium Chloride | Potassium Chloride | 629 | 140 |
| Gabapentin | Gabapentin | 596 | 146 |
| Trazodone Hcl | Trazodone Hcl | 590 | 136 |
| Omeprazole | Omeprazole | 533 | 126 |
| Metoprolol Succinate | Metoprolol Succinate | 521 | 133 |
| Furosemide | Furosemide | 502 | 136 |
| Duloxetine Hcl | Duloxetine Hcl | 465 | 123 |
| Mirtazapine | Mirtazapine | 446 | 92 |
| Lisinopril | Lisinopril | 438 | 110 |
| Alprazolam | Alprazolam | 435 | 72 |
| Metformin Hcl | Metformin Hcl | 419 | 99 |
| Hydrochlorothiazide | Hydrochlorothiazide | 398 | 118 |
| Buspirone Hcl | Buspirone Hcl | 383 | 67 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 354 | 89 |
| Tamsulosin Hcl | Tamsulosin Hcl | 352 | 79 |
| Simvastatin | Simvastatin | 332 | 86 |
| Escitalopram Oxalate | Escitalopram Oxalate | 324 | 72 |
| Montelukast Sodium | Montelukast Sodium | 322 | 71 |
| Pravastatin Sodium | Pravastatin Sodium | 296 | 74 |
| Sertraline Hcl | Sertraline Hcl | 293 | 61 |
| Meloxicam | Meloxicam | 280 | 63 |
| Carvedilol | Carvedilol | 272 | 62 |
| Hydralazine Hcl | Hydralazine Hcl | 265 | 53 |
| Clopidogrel | Clopidogrel Bisulfate | 264 | 60 |
| Quetiapine Fumarate | Quetiapine Fumarate | 253 | 32 |
| Clonazepam | Clonazepam | 248 | 40 |
| Donepezil Hcl | Donepezil Hcl | 236 | 58 |
| Prednisone | Prednisone | 231 | 86 |
| Allopurinol | Allopurinol | 222 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 217 | 67 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 213 | 58 |
| Enalapril Maleate | Enalapril Maleate | 209 | 50 |
| Glimepiride | Glimepiride | 208 | 53 |
| Famotidine | Famotidine | 194 | 49 |
| Metoprolol Tartrate | Metoprolol Tartrate | 182 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 177 | 77 |
| Xarelto | Rivaroxaban | 176 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 173 | 124 |
| Lorazepam | Lorazepam | 169 | 28 |
| Alendronate Sodium | Alendronate Sodium | 167 | 47 |
| Jardiance | Empagliflozin | 161 | 36 |
| Ropinirole Hcl | Ropinirole Hcl | 160 | 31 |
| Tramadol Hcl | Tramadol Hcl | 159 | 50 |
| Ondansetron Hcl | Ondansetron Hcl | 158 | 91 |
| Baclofen | Baclofen | 156 | 45 |
| Ezetimibe | Ezetimibe | 155 | 42 |
| Atenolol | Atenolol | 150 | 37 |
| Mounjaro | Tirzepatide | 148 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 146 | 25 |
| Divalproex Sodium | Divalproex Sodium | 145 | 28 |
| Glipizide | Glipizide | 144 | 30 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 130 | 33 |
| Spironolactone | Spironolactone | 130 | 42 |
| Methocarbamol | Methocarbamol | 128 | 38 |
| Oxycodone Hcl | Oxycodone Hcl | 128 | 23 |
| Pregabalin | Pregabalin | 128 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 124 | 20 |
| Finasteride | Finasteride | 123 | 34 |
| Ipratropium Bromide | Ipratropium Bromide | 121 | 45 |
| Levetiracetam | Levetiracetam | 119 | 18 |
| Memantine Hcl | Memantine Hcl | 118 | 27 |
| Sucralfate | Sucralfate | 118 | 30 |
| Tizanidine Hcl | Tizanidine Hcl | 116 | 31 |
| Meclizine Hcl | Meclizine Hcl | 115 | 35 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 112 | 80 |
| Celecoxib | Celecoxib | 111 | 30 |
| Doxazosin Mesylate | Doxazosin Mesylate | 111 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 105 | 60 |
| Torsemide | Torsemide | 104 | 27 |
| Ozempic | Semaglutide | 103 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 99 | 22 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 93 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 92 | 20 |
| Rexulti | Brexpiprazole | 91 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 88 | 29 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 88 | 24 |
| Metoclopramide Hcl | Metoclopramide Hcl | 87 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 87 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 86 | 25 |
| Synthroid | Levothyroxine Sodium | 86 | 22 |
| Bupropion Xl | Bupropion Hcl | 79 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 77 | 21 |
| Chlorthalidone | Chlorthalidone | 76 | 21 |
| Januvia | Sitagliptin Phosphate | 76 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 74 | 58 |
| Diclofenac Sodium | Diclofenac Sodium | 73 | 26 |
| Topiramate | Topiramate | 73 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 69 | 11 |
| Colestipol Hcl | Colestipol Hcl | 68 | 18 |
| Primidone | Primidone | 68 | 17 |
| Estradiol | Estradiol | 67 | 24 |
| Nifedipine Er | Nifedipine | 66 | 11 |
| Propranolol Hcl | Propranolol Hcl | 66 | 16 |
| Warfarin Sodium | Warfarin Sodium | 64 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 63 | 51 |
| Valacyclovir | Valacyclovir Hcl | 63 | 34 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 61 | suppressed |
| Nystatin | Nystatin | 61 | 40 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 60 | 18 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 59 | 17 |
| Mupirocin | Mupirocin | 59 | 34 |
| Clonidine Hcl | Clonidine Hcl | 57 | 25 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 57 | 26 |
| Myrbetriq | Mirabegron | 57 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 57 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 56 | 16 |
| Diazepam | Diazepam | 55 | 12 |
| Fluconazole | Fluconazole | 55 | 42 |
| Levofloxacin | Levofloxacin | 53 | 36 |
| Scopolamine | Scopolamine | 52 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 51 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 51 | 11 |
| Novolog Flexpen | Insulin Aspart | 51 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 49 | 12 |
| Bupropion Hcl Sr | Bupropion Hcl | 49 | 16 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 48 | 18 |
| Promethazine Hcl | Promethazine Hcl | 48 | 17 |
| Ramipril | Ramipril | 48 | 12 |
| Humulin R | Insulin Regular, Human | 47 | 12 |
| Propranolol Hcl Er | Propranolol Hcl | 46 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 45 | 11 |
| Colchicine | Colchicine | 45 | 22 |
| Digoxin | Digoxin | 45 | 12 |
| Nebivolol Hcl | Nebivolol Hcl | 45 | 11 |
| Trospium Chloride | Trospium Chloride | 45 | 18 |
| Cephalexin | Cephalexin | 44 | 25 |
| Entresto | Sacubitril/Valsartan | 44 | suppressed |
| Olanzapine | Olanzapine | 44 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 43 | 13 |
| Azelastine Hcl | Azelastine Hcl | 42 | 12 |
| Latanoprost | Latanoprost | 42 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 41 | 24 |
| Morphine Sulfate Er | Morphine Sulfate | 41 | suppressed |
| Valsartan | Valsartan | 41 | 12 |
| Aripiprazole | Aripiprazole | 40 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 40 | suppressed |
| Temazepam | Temazepam | 40 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 39 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 39 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 39 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 38 | 12 |
| Fentanyl | Fentanyl | 38 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 38 | 12 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 38 | suppressed |
| Lovastatin | Lovastatin | 37 | suppressed |
| Methylprednisolone | Methylprednisolone | 37 | 36 |
| Paxlovid | Nirmatrelvir/Ritonavir | 37 | 37 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 36 | suppressed |
| Bumetanide | Bumetanide | 35 | suppressed |
| Metolazone | Metolazone | 35 | 12 |
| Trintellix | Vortioxetine Hydrobromide | 35 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 34 | suppressed |
| Hydrocortisone | Hydrocortisone | 33 | 12 |
| Nexletol | Bempedoic Acid | 33 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 33 | 19 |
| Linzess | Linaclotide | 32 | suppressed |
| Methimazole | Methimazole | 32 | suppressed |
| Metronidazole | Metronidazole | 32 | 25 |
| Verapamil Er | Verapamil Hcl | 32 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 24 |
| Cefdinir | Cefdinir | 31 | 28 |
| Diltiazem Hcl | Diltiazem Hcl | 31 | suppressed |
| Multaq | Dronedarone Hcl | 31 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Indapamide | Indapamide | 30 | suppressed |
| Lacosamide | Lacosamide | 30 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 30 | suppressed |
| Nitroglycerin | Nitroglycerin | 30 | 19 |
| Ventolin Hfa | Albuterol Sulfate | 30 | 17 |
| Midodrine Hcl | Midodrine Hcl | 29 | 11 |
| Cefuroxime | Cefuroxime Axetil | 28 | 25 |
| Ondansetron Odt | Ondansetron | 28 | 15 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | 11 |
| Clobetasol Propionate | Clobetasol Propionate | 27 | 13 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 27 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 26 | 17 |
| Irbesartan | Irbesartan | 26 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 26 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 26 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 25 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 25 | suppressed |
| Testosterone | Testosterone | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 21 |
| Clindamycin Hcl | Clindamycin Hcl | 23 | 16 |
| Gemfibrozil | Gemfibrozil | 23 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 23 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 23 | suppressed |
| Cimetidine | Cimetidine | 22 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 22 | 13 |
| Rivastigmine | Rivastigmine | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Trimethoprim | Trimethoprim | 21 | suppressed |
| Roflumilast | Roflumilast | 20 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 20 | suppressed |
| Telmisartan | Telmisartan | 20 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 19 | suppressed |
| Brilinta | Ticagrelor | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Felodipine Er | Felodipine | 19 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Modafinil | Modafinil | 19 | suppressed |
| Novolin R | Insulin Regular, Human | 19 | suppressed |
| Verapamil Sr | Verapamil Hcl | 19 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 18 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 18 | suppressed |
| Humalog | Insulin Lispro | 18 | suppressed |
| Lidocaine | Lidocaine | 18 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | 17 |
| Glyburide | Glyburide | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 16 | 16 |
| Minoxidil | Minoxidil | 16 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 16 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Tradjenta | Linagliptin | 16 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 15 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 15 | suppressed |
| Rytary | Carbidopa/Levodopa | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 14 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Yuvafem | Estradiol | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Glipizide Er | Glipizide | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Mitigare | Colchicine | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 12 | suppressed |
| Budesonide Dr | Budesonide | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Celebrex | Celecoxib | 12 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | 11 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Renacidin | Citric Ac/Gluconolact/Mag Carb | 12 | suppressed |
| Triazolam | Triazolam | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 11 | suppressed |
| Budesonide | Budesonide | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Carisoprodol | Carisoprodol | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Klor-Con 10 | Potassium Chloride | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Premarin | Estrogens, Conjugated | 11 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 11 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 11 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $128.59 · 8 records | Abbott Laboratories | Cologuard Collection Kit, ELIQUIS, FREESTYLE LIBRE 3, MOUNJARO, NURTEC ODT, Wegovy, ZAVZPRET | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Eliquis play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error